Reuters has published a compelling analysis of ongoing challenges facing pharmaceutical “rogue” Valeant with a focus on its price-inflated drug Syprine and its relationship with also-beleagured pharma company Kadmon. Among other issues, Valeant has been singled out as a prime offender in the realm of hyper-inflated pharmaceutical drugs, with, Syprine, its life-saving Wilson’s disease liver ailment treatment costing some patients nearly $300,000 for a year’s use (in 2011, Valeant priced the drug at less than $1,000 for 100 capsules, a rate that rose by 2015 to over $21,000 for the same dose). [Read more…]
Lieff Cabraser partner Dean M. Harvey will be moderating an American Bar Association panel discussion entitled “Competition Torts in the Trenches: Lessons From Recent High-Profile Cases.” The panel will take place on November 21, 2016 from 12:30-1:30pm ET. [Read more…]
The Hollywood Reporter reports that 21st Century Fox has sued streaming video company Netflix in Los Angeles Superior Court for improperly poaching its employees. In the lawsuit, the film and television studio claimed that Netflix ran a “brazen campaign to unlawfully target, recruit, and poach valuable Fox executives by illegally inducing them to break their employment contracts with Fox to work at Netflix.” [Read more…]
Lieff Cabraser partner Dean M. Harvey will be featured as a distinguished speaker on an Association of Business Trial Lawyers (ABTL) panel titled “Are Computers About to Eat Your Lunch (Or At Least Change the Way You Practice)?” The event will take place on August 30, 2016 at The Four Seasons Hotel in San Francisco. [Read more…]
The Second Circuit has invalidated a $7.25 billion antitrust settlement between Visa and MasterCard relating to interchange fees. A June 30 Law360 article (subscription) sees this as a “powerful signal” that class reps must be extremely careful about seeking case resolutions that might “[compromise] someone else’s fundamentally conflicting interests.” [Read more…]
Lieff Cabraser partner Dean M. Harvey will be moderating an American Bar Association (ABA) panel titled “The Law and Economics of Employee Non-Compete Agreements” on June 22, 2016 from 12:00-1:00pm ET. [Read more…]
Lieff Cabraser partner Dean M. Harvey spoke with Law360 to offer advice to antitrust lawyers on “five writing mistakes that can tilt the balance against your antitrust clients.” Along with Hausfeld LLP’s Scott Martin and Daniel Francis of Hunton & Williams, Mr. Harvey was tapped by the legal journal for his knowledge and expertise in the face of an inherent problem for antitrust attorneys created by “the complexity of competition law [which] puts them at a heightened risk of hurting their chances of victory by writing briefs that judges struggle to read.” [Read more…]
Lieff Cabraser partner Dean Harvey provided a wealth of useful content to Law360‘s recent article, “5 Career Tips For Aspiring Antitrust Lawyers.” The piece, which seeks to instruct fledgling competition attorneys on developing their skill set, contains numerous tips and guidelines for mastering antitrust law and carving out a practice aimed at becoming “a top-tier antitrust practitioner.” [Read more…]
The Federal Trade Commission (FTC) has made its first outright challenge towards so-called “no-authorized-generics” agreements between branded drug makers and generic drug companies. The agency initiated legal action against Endo Pharmaceuticals Inc. and other drugmakers for making anti-competitive payments through the mechanism of illegally withholding authorization for the production of generic versions of certain drugs. The FTC concludes these pharmaceutical companies violated antitrust laws by blocking lower-cost generic versions of branded drugs from consumers with pay-for-delay payments.
Lieff Cabraser attorneys selected as California Lawyers of the Year for antitrust case against Bayer over anticompetitive pricing of the blockbuster antibiotic drug Ciproflaxacin, sold as Cipro
California Lawyer has selected Lieff Cabraser partners Eric Fastiff, Brendan Glackin, and Dean Harvey as recipients of its 20th annual California Lawyer Attorneys of the Year (CLAY) Award. The prestigious award is given to lawyers whose work had a significant impact in the preceding year. The team was recognized for their outstanding work on In re Cipro Cases I & II, JCCP 4154/4220, a case that led the California Supreme Court to resoundingly endorse the rights of consumers to challenge pharmaceutical “pay-for-delay” settlements under California competition law.
According to The Recorder, “The groundbreaking [High-Tech Antitrust] class action, one of the first to successfully apply antitrust law to employment activity, has ushered in a wave of similar suits targeting California animation studios, North Carolina medical schools, a mixed martial arts promoter and additional tech companies.” [Read more…]
On May 27, 2015, the U.S. Attorney’s Office for the Eastern District of New York announced a 47-count indictment charging nine FIFA officials and five corporate executives with a vast, 24-year scheme to “enrich themselves through the corruption of international soccer.” Soccer officials solicited and received over $150 million in bribes from sports marketing companies in return for lucrative marketing rights — including television and radio broadcasting rights, advertising rights, sponsorship rights, licensing rights, hospitality rights, and ticketing rights — to FIFA events and matches.
Lieff Cabraser partners Joy A. Kruse and Dean M. Harvey will be discussing the latest trends in class actions at the Eleventh Annual Comprehensive Conference on Class Actions on June 4th & 5th in Seattle, Washington. Hosted by Law Seminars International, the conference will bring together distinguished practitioners in state and federal class actions. Ms. Kruse will address developments in securities law on a panel entitled “Raising Capital: Class Actions and Market Manipulation.” Mr. Harvey will speak on the “Cases at the Intersection of Class Actions and Employee Protection Regulations” panel.
The American Bar Association (ABA) Section of Antitrust Law and the Section of Labor and Employment Law presents a panel discussion titled “From High-Tech Labor to Sandwich Artists: The Law and Economics of Employee Solicitation and Hiring” on March 25, 2015. Lieff Cabraser attorney Dean M. Harvey will serve as moderator for this event.
The American Bar Association (ABA) Section of Antitrust Law Business Torts & Civil RICO Committee (BTCR) presents a Town Hall Meeting on December 15, 2014. Lieff Cabraser attorney Dean M. Harvey will be featured as a panelist in a discussion about the committee’s mission, leadership, and volunteer opportunities.